A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)

NCT06756295 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer, Colorectal Cancer
Melanoma
Lung Cancer

Interventions

BIOLOGICAL: individualized tumor FAST vaccine combination (including adjuvant)

Sponsor

Fengming Kong

Collaborators

[object Object]
[object Object]